Fig. 2From: The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK BiobankHazard ratios and 95% confidence intervals for the association of A NAFLD and B advanced liver fibrosis in people with NAFLD, with primary outcomes for people with CKD following full multivariable adjustmentBack to article page